Armistice Capital, LLC 13D and 13G filings for Biodexa Pharmaceuticals Plc:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-02-17 9:55 pm Purchase | 2025-12-31 | 13G | BIODEXA PHARMACEUTICALS INC SP BDRX | Armistice Capital, LLC | 56,700 9.990% | 56,680 (+283400.00%) | Filing |